A quote from Larry Glass, CSO of Neuren: "Our goal is to get NNZ-2591 approved and make it available as quickly as humanly possible.
On social media in Phelan chats
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-207
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.79 |
Change
-0.180(0.90%) |
Mkt cap ! $2.535B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.96 | $19.71 | $1.110M | 56.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19 | $19.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.79 | 118 | 6 |
View Market Depth
| Last trade - 11.35am 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |